Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results

Go back to Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.50 +0.01 (2.04%)
Previous Close $0.49    52 Week High
Open $0.49    52 Week Low
Day High $0.50    P/E N/A 
Day Low $0.48    EPS
Volume 330,179